• Aim of the literature search was to better understand HRQoL in splenectomized ITP-patients compared to nonsplenectomized patients.
• Research questions were: How is the HRQOL affected in splenectomized ITP patients; is HRQoL worse after splenectomy, is there a difference in HRQoL between splenectomized and non-splenectomized patients?
• A targeted literature search was conducted via Ovid (Medline, Embase, and Cochrane) in September 2014 to assess the research question.
• Search strings were based on PICO-criteria (Population, Intervention, Control and Outcomes).
• Inclusion criteria: Studies of adult patients with ITP that contained information on HRQoL; clinical trials, RCTs, meta-analyses, observational trials, retrospective studies or systematic reviews; manuscripts and congress abstracts in English or German language.
• Exclusion criteria: No relevant information to answer the research questions (E1); language other than German or English (E2) and inclusion criteria not met (E3).
• Of the four studies using the ITP-PAQ, two reported no difference 5, 6 and two found worse HRQoL in splenectomized versus nonsplenectomized patients (see Figure 2 ). 7, 8 • As the studies using ITP-PAQ vary highly in patient numbers and show a high heterogeneity in patient characteristics, outcomes need to be interpreted with caution as differences did not always reach clinical relevance in every scale between splenectomized and nonsplenectomized patients. 5, 6, 7, 8 • George et al. identified significant differences in baseline HRQoL levels in six scales (symptoms, bother, activity, fear, social activity and women's reproductive health) in non-splenectomized compared to splenectomized patients. 7
• In the only study that included both generic (SF-36, EQ-5D) and ITP-specific measures, the generic measure scores were similar for splenectomized and non-splenectomized patients and the ITP-specific measure scores were worse for splenectomized patients. 8
• Detailed results were not provided in all studies and HrQoL was not reported according to response to therapy in any study.
RESULTS

ISPOR 18th
Annual European Congress, 7-11 November 2015; Milan, Italy (PSY98)
• Immune thrombocytopenia (ITP) is associated with a risk of spontaneous and excessive bleeding. 1,2
• Among the treatment options are medical therapies and splenectomy -a major intervention with lifelong consequences for the patient. 1,2
• Both ITP and ITP-treatment may impact health-related quality of life (HRQoL); therefore, a literature search was conducted to assess HRQoL of splenectomized compared to non-splenectomized ITP patients. • The impact of splenectomy on HRQoL in patients with ITP is inconclusive and inconsistently reported in the literature.
RESULTS
METHODS
• Due to use of different instruments, diverse patient characteristics, and pooling of data among responding and non-responding patients, HRQoL in ITP-patients with or without splenectomy can not be properly assessed at the moment.
• As most results did not reach clinical relevance, differences in HRQoL in splenectomized and non-splenectomized patients via ITP-PAQ scale cannot be generalized.
• Further studies are needed to address the question "impact of splenectomy on HRQoL in patients with ITP" within patients, where splenectomy has not failed before.
• For further investigation of HRQoL in ITP-patients it is recommended to use only one instrument (e.g. diseasespecific) to estimate changes in HRQoL before and after splenectomy. 
CONCLUSIONS
• The search identified 148 potentially relevant publications. After removing duplicates, 120 titles and abstracts were screened.
• Following the title / abstract screening, a full text screening (n=21) identified six relevant publications 3, 4, 5, 6, 7, 8 (see Figure 1 ). Full text screening n = 21
• HRQoL was assessed in these six publications using generic (SF-36, n=2; EQ-5D, n=1) 4,8 and disease-specific (ITP-PAQ, n=4) 5,6,7,8 instruments (see Table 1 ).
• Two studies using generic instruments reported no difference in HRQoL between splenectomized and nonsplenectomized patients. 3,4,8
